Oxford Biotrans
PrivateLast Round
Grant
Sep 1, 2022
Total Funding Raised
$8.44M
Company Overview
Oxford Biotrans is an industrial biotechnology company that develops and commercializes enzymatic process technologies to produce high-value chemical compounds, such as natural-grade flavors and fragrances.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oxford Biotrans Comparables
Compare Oxford Biotrans with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Manus Bio | 85% | |
| Conagen | 81% | |
| BASF India Limited | 78% |
For institutional investors. Book with your work email.
Oxford Biotrans Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2022 | ||||
| Grant | Sep 1, 2020 | ||||
| Early Funding | Oct 10, 2017 | ||||
| Series A | Aug 4, 2015 | ||||
| Seed | Sep 30, 2013 |
For institutional investors. Book with your work email.
Oxford Biotrans Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizon Europe Guarantee | Grant |
| IP Group | Seed, Series A |
| Perivoli Innovations | Early Funding |
| University of Oxford | Seed, Early Funding, Series A |
| OTIF Ventures | Early Funding |
| Imperial Innovations | Early Funding, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2022
$310K secured from Horizon Europe Guarantee
- Sep 1, 2020
$330K grant round completed.
For institutional investors. Book with your work email.
Oxford Biotrans Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oxford Biotrans's valuation, stock price, and market status.
Is Oxford Biotrans a public or private company?
Oxford Biotrans is a private company.
What is the current stock price of Oxford Biotrans?
Oxford Biotrans is a private company, so its shares have no public market price. Caplight tracks Oxford Biotrans's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oxford Biotrans worth (valuation)?
Valuation information for Oxford Biotrans is not publicly available.
Can I buy Oxford Biotrans stock?
Oxford Biotrans shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oxford Biotrans's last funding round?
Oxford Biotrans's most recent funding round was Grant on September 1, 2022.
Who are the main investors in Oxford Biotrans?
Key investors in Oxford Biotrans include Imperial Innovations.
Will Oxford Biotrans IPO soon?
No public IPO plans have been announced for Oxford Biotrans.
How can I track Oxford Biotrans secondary market activity?
Caplight tracks bids, offers, and trades in Oxford Biotrans's shares on secondary markets.